These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 29672637

  • 1. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N, Duong DC, Tong HV, Hien TTT, Hoan PQ, Bang MH, Binh MT, Ky TD, Tung NL, Thinh NT, Sang VV, Thao LTP, Bock CT, Velavan TP, Meyer CG, Song LH, Toan NL.
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [Abstract] [Full Text] [Related]

  • 2. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 3. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X, Liu J, Jiao X, Du Z.
    Cancer Biomark; 2015 Sep; 15(2):171-80. PubMed ID: 25519019
    [Abstract] [Full Text] [Related]

  • 4. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [Abstract] [Full Text] [Related]

  • 5. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L, Lu B, Yu J, Liu W, Zhou A.
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C.
    PLoS One; 2016 Sep; 11(4):e0153227. PubMed ID: 27070780
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma.
    Trung NT, Hoan NX, Trung PQ, Binh MT, Van Tong H, Toan NL, Bang MH, Song LH.
    Sci Rep; 2020 May 18; 10(1):8181. PubMed ID: 32424223
    [Abstract] [Full Text] [Related]

  • 8. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.
    Panminerva Med; 2017 Dec 18; 59(4):283-289. PubMed ID: 28650134
    [Abstract] [Full Text] [Related]

  • 9. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 10. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F, Lu Z, Chen B, Dong P, Zheng J.
    Diagn Pathol; 2015 Jul 28; 10():129. PubMed ID: 26215970
    [Abstract] [Full Text] [Related]

  • 11. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Shen Y, Chen J, Wu J, Li T, Yi C, Wang K, Wang P, Sun C, Ye H.
    Cancer Prev Res (Phila); 2024 May 02; 17(5):227-235. PubMed ID: 38489403
    [Abstract] [Full Text] [Related]

  • 12. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May 02; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 13. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

  • 14. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X, Peng S, Xiao X, Huang Z, Zhang P.
    Sci Rep; 2024 May 14; 14(1):10996. PubMed ID: 38744926
    [Abstract] [Full Text] [Related]

  • 15. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH, Fang Y, Wang JW, Yuan XD, Fan YC, Gao S, Han LY, Wang K.
    Medicine (Baltimore); 2020 May 14; 99(20):e20326. PubMed ID: 32443384
    [Abstract] [Full Text] [Related]

  • 16. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL.
    Sci Rep; 2019 Jul 18; 9(1):10464. PubMed ID: 31320713
    [Abstract] [Full Text] [Related]

  • 17. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L, Wang Y, Wang D, Han G, Fu S, Wang J.
    PLoS One; 2017 Jul 18; 12(9):e0183880. PubMed ID: 28902891
    [Abstract] [Full Text] [Related]

  • 18. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN.
    Mol Biol Rep; 2014 Jul 18; 41(7):4513-9. PubMed ID: 24595450
    [Abstract] [Full Text] [Related]

  • 19. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
    Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J.
    J Clin Oncol; 2011 Dec 20; 29(36):4781-8. PubMed ID: 22105822
    [Abstract] [Full Text] [Related]

  • 20. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H.
    Tumour Biol; 2016 May 20; 37(5):6539-49. PubMed ID: 26637228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.